Cost-Utility Analysis for Colorectal Cancer Screening According to the Initiating Age of National Cancer Screening Program in Korea

被引:1
|
作者
Bae, Seowoo [1 ,2 ]
Lee, Kyeongmin [3 ]
Kim, Byung Chang [4 ]
Jun, Jae Kwan [1 ,3 ]
Choi, Kui Son [1 ,3 ]
Suh, Mina [1 ,3 ,5 ]
机构
[1] Natl Canc Control Inst, Natl Canc Ctr, Goyang, South Korea
[2] Ewha Womans Univ, Dept Hlth Convergence, Seoul, South Korea
[3] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, South Korea
[4] Res Inst & Hosp, Ctr Colorectal Canc, Natl Canc Ctr, Goyang, South Korea
[5] Natl Canc Control Inst, Natl Canc Ctr, Western Tower 4,24 Jeongbalsan Ro, Goyang 10403, South Korea
关键词
Colorectal Cancer; Early Detection of Cancer; Economic Evaluation; FECAL IMMUNOCHEMICAL TESTS; METAANALYSIS; COLONOSCOPY; STRATEGIES; MORTALITY;
D O I
10.3346/jkms.2024.39.e98
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study aimed to identify the most cost-effective strategy for colorectal cancer screening using the fecal immunochemical test (FIT), focusing on screening initiation age in Korea. Methods: We designed Markov simulation models targeting individuals aged 40 years or older. Twelve strategies combining screening initiation ages (40, 45, or 50 years old), termination ages (80 or no limit), and intervals (1 or 2 years) were modeled, and the most cost-effective strategy was selected. The robustness of the results was confirmed using one-way and probabilistic sensitivity analyses. Furthermore, the cost-effectiveness of the qualitative and quantitative FIT methods was verified using scenario analysis. Results: The 2 -year interval strategy with a screening age range of 45-80 years was the most cost-effective (incremental cost -utility ratio = KRW 7,281,646/quality adjusted life years). The most sensitive variables in the results were transition rate from advanced adenoma to local cancer and discount rate. The uncertainty in the model was substantially low. Moreover, strategies starting at the age of 40 years were also cost-effective but considered suboptimal. The scenario analysis showed that there was no significant difference in cost-effectiveness between strategies with various relative screening ratio of quantitative and qualitative method. Conclusion: The screening method for advancing the initiation age, as presented in the 2015 revised national screening recommendations, was superior regarding cost-effectiveness. This study provides a new paradigm for the development of a national cancer screening system in Korea, which can be utilized as a scientific basis for economic evaluations.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Neonatal Screening: Cost-utility Analysis for Galactosemia
    Hatam, Nahid
    Askarian, Mehrdad
    Shirvani, Samad
    Siavashi, Elham
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2017, 46 (01) : 112 - 119
  • [42] COST-UTILITY ANALYSIS OF LUNG CANCER SCREENING COMBINED WITH CARDIOVASCULAR DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE SCREENING
    Behr, C.
    Ijzerman, M.
    Kip, M. M. A.
    Vliegenthart, R.
    Koffijberg, H.
    VALUE IN HEALTH, 2022, 25 (12) : S75 - S75
  • [43] Endoscopy for Upper Gastrointestinal (UGI) Cancer Screening in the General Population: A Cost-Utility Analysis
    Gupta, Neil
    Bansal, Ajay
    Wani, Sachin B.
    Rastogi, Amit
    Gaddam, Srinivas
    Singh, Vikas
    Singh, Mandeep
    Sharma, Prateek
    GASTROENTEROLOGY, 2010, 138 (05) : S152 - S152
  • [44] Cost-effectiveness Outcomes of the National Gastric Cancer Screening Program in South Korea
    Cho, Eun
    Kang, Moon Hae
    Choi, Kui Son
    Suh, MiNa
    Jun, Jae Kwan
    Park, Eun-Cheol
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (04) : 2533 - 2540
  • [45] Cost-utility analysis of nonalcoholic steatohepatitis screening
    Eric Zhang
    Claire Wartelle-Bladou
    Luigi Lepanto
    Jean Lachaine
    Guy Cloutier
    An Tang
    European Radiology, 2015, 25 : 3282 - 3294
  • [46] A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity
    Andrea M. Teng
    Giorgi Kvizhinadze
    Nisha Nair
    Melissa McLeod
    Nick Wilson
    Tony Blakely
    BMC Infectious Diseases, 17
  • [47] A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity
    Teng, Andrea M.
    Kvizhinadze, Giorgi
    Nair, Nisha
    McLeod, Melissa
    Wilson, Nick
    Blakely, Tony
    BMC INFECTIOUS DISEASES, 2017, 17
  • [48] Cost-utility analysis of genetic polymorphism universal screening in colorectal cancer prevention by detection of high-risk individuals
    Pereira, Carina
    Areia, Miguel
    Dinis-Ribeiro, Mario
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (12) : 1731 - 1737
  • [49] Cost-Effectiveness Analysis of Hypertension Screening in the Korea National Health Screening Program
    Lee, Hae Young
    Lee, Seung Won
    Kim, Hyeon Chang
    Ihm, Sang Hyun
    Ha Park, Sung
    Kim, Tae Hyun
    KOREAN CIRCULATION JOURNAL, 2021, 51 (07) : 610 - 622
  • [50] Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009-2014
    Shim, Seung-Hyuk
    Kim, Hyeongsu
    Sohn, In-Sook
    Hwang, Han-Sung
    Kwon, Han-Sung
    Lee, Sun Joo
    Lee, Ji Young
    Kim, Soo-Nyung
    Lee, Kunsei
    Chang, Sounghoon
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2017, 28 (05)